Index of reports
> Death (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bisoprolol death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Bisoprolol side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06
Patient: 47 year old female
Reactions: Jaundice, Pruritus, Disseminated Intravascular Coagulation, Cholestasis, Hepatic Failure, Pyrexia, Hepatic Encephalopathy, Hepatitis Fulminant, Vomiting, Nausea, Cytolytic Hepatitis, Alanine Aminotransferase Increased, Gastrointestinal Disorder, Aspartate Aminotransferase Increased, Escherichia Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2009-04-15
End date: 2009-08-11
Plavix
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Stent Placement
Start date: 2009-04-15
End date: 2009-08-11
Bisoprolol
Dosage: unk
Administration route: Oral
Indication: Myocardial Infarction
Start date: 2009-04-15
End date: 2009-08-28
Aspirin
Dosage: unk
Indication: Myocardial Infarction
Start date: 2009-04-15
End date: 2009-08-28
Omacor
Dosage: unk
Indication: Myocardial Infarction
Start date: 2009-04-15
End date: 2009-07-30
Atorvastatin
Dosage: unk
Administration route: Oral
Start date: 2009-04-15
End date: 2009-07-13
Possible Bisoprolol side effects in 53 year old male
Reported by a physician from United States on 2012-01-23
Patient: 53 year old male
Reactions: Overdose, Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Venlafaxine HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Bupropion Hydrochloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Bisoprolol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Hydrodiuril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Atorvastatin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Bisoprolol side effects in 53 year old male
Reported by a physician from United States on 2012-01-12
Patient: 53 year old male
Reactions: Poisoning, Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Bisoprolol
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Atorvastatin
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Venlafaxine
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Bupropion Hydrochloride
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Hydrochlorothiazide
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Bisoprolol side effects in 53 year old male
Reported by a physician from United States on 2012-01-12
Patient: 53 year old male
Reactions: Poisoning, Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Venlafaxine
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Bupropion Hydrochloride
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Bisoprolol
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Hydrochlorothiazide
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Atorvastatin
Dosage: (df oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Bisoprolol side effects in 53 year old male
Reported by a physician from United States on 2011-12-22
Patient: 53 year old male
Reactions: Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
Bupropion
Hydrochlorothiazide
Atorvastatin Calcium
Venlafaxine HCL
Bisoprolol
Amlodipine Besylate
Possible Bisoprolol side effects in female
Reported by a physician from Germany on 2011-10-04
Patient: female, weighing 103.0 kg (226.6 pounds)
Reactions: Electrocardiogram QT Prolonged, Heart Rate Decreased, Sudden Cardiac Death, Electrocardiogram QRS Complex Prolonged
Adverse event resulted in: death
Drug(s) suspected as cause:
Bisoprolol
Dosage: 10 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-07-10
Olmesartan Medoxomil
Dosage: 40 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2010-06-10
Enoxaparin Sodium
Dosage: 100 mg/day
Indication: Atrial Fibrillation
Start date: 2010-11-08
Rasilez
Dosage: 300 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-06
Torsemide
Dosage: 10 mg/day
Start date: 2010-08-20
Other drugs received by patient: Calcium Channel Blockers; Angiotensin Receptor Blocker (Other Than Valsartan); ACE Inhibitors
Possible Bisoprolol side effects in female
Reported by a physician from Germany on 2011-10-04
Patient: female, weighing 103.0 kg (226.6 pounds)
Reactions: Electrocardiogram QT Prolonged, Heart Rate Decreased, Sudden Cardiac Death, Electrocardiogram QRS Complex Prolonged
Adverse event resulted in: death
Drug(s) suspected as cause:
Torasemide
Dosage: 10 mg/day
Start date: 2010-08-20
Olmesartan Medoxomil
Dosage: 40 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2010-06-10
Enoxaparin Sodium
Dosage: 100 mg/day
Indication: Atrial Fibrillation
Start date: 2010-11-08
Rasilez
Dosage: 300 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-06
Bisoprolol
Dosage: 10 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2008-07-10
Other drugs received by patient: Calcium Channel Blockers; ACE Inhibitors; Angiotensin Receptor Blocker (Other Than Valsartan)
|